Terms: = Lymphoma AND FCRL4, FCRH4, 83417, ENSG00000163518, IRTA1, IGFP2
25 results:
1. The first autopsy case of Epstein-Barr virus-positive marginal zone lymphoma that deteriorated after COVID-19 vaccination.
Wang Z; Muto R; Miyoshi H; Aoki M; Uesugi N; Murayama H; Masutani K; Hamasaki M
Pathol Int; 2024 Feb; 74(2):87-92. PubMed ID: 38116849
[TBL] [Abstract] [Full Text] [Related]
2. Nodal reactive proliferation of monocytoid B-cells may represent atypical memory B-cells.
Yu SC; Chen KC; Huang RY
J Microbiol Immunol Infect; 2023 Aug; 56(4):729-738. PubMed ID: 37080839
[TBL] [Abstract] [Full Text] [Related]
3. The Distinctive Nature of Thyroid MALT lymphomas Including irta1 Expression.
Carlsen ED; Davis AR; Cook JR; Swerdlow SH
Am J Surg Pathol; 2023 Mar; 47(3):370-378. PubMed ID: 36729757
[TBL] [Abstract] [Full Text] [Related]
4. Lymphoplasmacytic lymphoma with IgG-κ paraproteinemia presenting as a hepatic bulky mass.
Higuchi M; Senoo T; Morita C; Furugo I; Hamada T; Ohshima K
J Clin Exp Hematop; 2022; 62(4):273-278. PubMed ID: 36575005
[TBL] [Abstract] [Full Text] [Related]
5. Immunohistochemistry for irta1 and MNDA helps differentiate gastric MALT lymphoma from chronic gastritis/reactive lymphocyte hyperplasia.
Ayada Y; Igawa T; Naoi Y; Horikawa K; Tabata T; Tanaka T; Yoshino T
J Clin Exp Hematop; 2022 Dec; 62(4):195-201. PubMed ID: 36436933
[TBL] [Abstract] [Full Text] [Related]
6. Relevance of Additional Immunohistochemical Markers in the Differential Diagnosis of Small B-Cell lymphomas: A Case-Control Study.
Kıvrak H; Yüksel S; Ateş C; Merter M; Kaygusuz G; Özcan M; Kuzu I
Turk J Haematol; 2022 Aug; 39(3):178-187. PubMed ID: 34619856
[TBL] [Abstract] [Full Text] [Related]
7. irta1 positivity helps identify a MALT-lymphoma-like subset of primary cutaneous marginal zone lymphomas, largely but not exclusively defined by IgM expression.
Carlsen ED; Bhavsar S; Cook JR; Swerdlow SH
J Cutan Pathol; 2022 Jan; 49(1):55-60. PubMed ID: 34309899
[TBL] [Abstract] [Full Text] [Related]
8. The Multiple Roles of B Cells in the Pathogenesis of Sjögren's Syndrome.
Du W; Han M; Zhu X; Xiao F; Huang E; Che N; Tang X; Zou H; Jiang Q; Lu L
Front Immunol; 2021; 12():684999. PubMed ID: 34168653
[TBL] [Abstract] [Full Text] [Related]
9. Repertoire Analysis of B-Cells Located in Striated Ducts of Salivary Glands of Patients With Sjögren's Syndrome.
Visser A; Verstappen GM; van der Vegt B; Vissink A; Bende RJ; Bootsma H; Bos NA; Kroese FGM
Front Immunol; 2020; 11():1486. PubMed ID: 32760405
[TBL] [Abstract] [Full Text] [Related]
10. Gene expression profiling of epithelium-associated fcrl4
Verstappen GM; Ice JA; Bootsma H; Pringle S; Haacke EA; de Lange K; van der Vries GB; Hickey P; Vissink A; Spijkervet FKL; Lessard CJ; Kroese FGM
J Autoimmun; 2020 May; 109():102439. PubMed ID: 32201227
[TBL] [Abstract] [Full Text] [Related]
11. irta1 and MNDA Expression in Marginal Zone lymphoma: Utility in Differential Diagnosis and Implications for Classification.
Wang Z; Cook JR
Am J Clin Pathol; 2019 Feb; 151(3):337-343. PubMed ID: 30346478
[TBL] [Abstract] [Full Text] [Related]
12. fcrl4
Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
[TBL] [Abstract] [Full Text] [Related]
13. Immunohistochemical analysis of the novel marginal zone B-cell marker irta1 in malignant lymphoma.
Ikeda JI; Kohara M; Tsuruta Y; Nojima S; Tahara S; Ohshima K; Kurashige M; Wada N; Morii E
Hum Pathol; 2017 Jan; 59():70-79. PubMed ID: 27666766
[TBL] [Abstract] [Full Text] [Related]
14. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.
van den Brand M; Rijntjes J; Hebeda KM; Menting L; Bregitha CV; Stevens WB; van der Velden WJ; Tops BB; van Krieken JH; Groenen PJ
Histopathology; 2017 Jan; 70(2):174-184. PubMed ID: 27297871
[TBL] [Abstract] [Full Text] [Related]
15. Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of irta1 and T-bet as positive markers.
Bob R; Falini B; Marafioti T; Paterson JC; Pileri S; Stein H
Histopathology; 2013 Oct; 63(4):482-98. PubMed ID: 23855758
[TBL] [Abstract] [Full Text] [Related]
16. irta1 is selectively expressed in nodal and extranodal marginal zone lymphomas.
Falini B; Agostinelli C; Bigerna B; Pucciarini A; Pacini R; Tabarrini A; Falcinelli F; Piccioli M; Paulli M; Gambacorta M; Ponzoni M; Tiacci E; Ascani S; Martelli MP; Dalla Favera R; Stein H; Pileri SA
Histopathology; 2012 Nov; 61(5):930-41. PubMed ID: 22716304
[TBL] [Abstract] [Full Text] [Related]
17. Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.
Charles ED; Brunetti C; Marukian S; Ritola KD; Talal AH; Marks K; Jacobson IM; Rice CM; Dustin LB
Blood; 2011 May; 117(20):5425-37. PubMed ID: 21421840
[TBL] [Abstract] [Full Text] [Related]
18. T-bet-positive and irta1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution.
Jöhrens K; Shimizu Y; Anagnostopoulos I; Schiffmann S; Tiacci E; Falini B; Stein H
Haematologica; 2005 Aug; 90(8):1070-7. PubMed ID: 16079106
[TBL] [Abstract] [Full Text] [Related]
19. Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.
Zinzani PL; Dirnhofer S; Sabattini E; Alinari L; Piccaluga PP; Stefoni V; Tani M; Musuraca G; Marchi E; Falini B; Baccarani M; Pileri SA
Haematologica; 2005 Mar; 90(3):341-7. PubMed ID: 15749666
[TBL] [Abstract] [Full Text] [Related]
20. Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR.
Sonoki T; Willis TG; Oscier DG; Karran EL; Siebert R; Dyer MJ
Leukemia; 2004 Dec; 18(12):2026-31. PubMed ID: 15496980
[TBL] [Abstract] [Full Text] [Related]
[Next]
